In the manufacturing process of active pharmaceutical ingredients (APIs), the extraction and separation of reaction mixtures is a critical step that determines product purity, yield, and production cost. Traditional batch extraction processes typically use reactors or mixer settlers, which face common industry challenges such as low mass transfer efficiency, high solvent consumption, significant batch-to-batch variability, and difficulty handling emulsions. With the pharmaceutical industry's increasing emphasis on continuous production, green manufacturing, and GMP compliance, centrifugal extraction technology has become the mainstream approach for upgrading API reaction liquid extraction processes.

Technical Challenges in API Reaction Liquid Extraction

API reaction liquid is complex, usually containing the target API molecules, unreacted raw materials, by-products, and residual catalysts. Traditional batch extraction faces significant bottlenecks: slow mass transfer rates require multiple stages and large equipment footprints; high solvent entrainment increases recovery costs; operations rely heavily on operator experience, making batch-to-batch consistency difficult to ensure; and open handling increases the risk of VOC emissions, for thermally sensitive APIs in particular, prolonged exposure may lead to degradation or decomposition of the active components.

Working Principle and Technical Advantages of the CWL-M Centrifugal Extractor

The CWL-M centrifugal extractor generates a high-speed centrifugal field, enabling thorough mixing of API reaction liquids with the extractant at a micrometer scale, followed by rapid separation. This process reduces the traditional extraction cycle from several hours to just 1–2 minutes, with single-stage extraction efficiency exceeding 90%. Multi-stage series operation allows continuous countercurrent extraction, significantly enhancing mass transfer driving force and achieving higher extraction efficiency with fewer stages.

In API extraction applications, centrifugal extractor demonstrates multiple core advantages:

1.Increased Efficiency and Reduced Cost: Mass transfer efficiency improves by 30%–50%, substantially reducing equipment size and footprint. Solvent entrainment is extremely low (typically <0.1%), significantly lowering solvent purchase and recovery costs.
2.Quality Assurance and Compliance: Fully enclosed design prevents solvent evaporation, meeting stringent GMP and EHS standards. Process parameters (rotation speed, flow ratio, temperature) are precisely controllable, ensuring high batch-to-batch consistency and strong support for process validation.
3.Adaptability to Complex Systems: Capable of purifying a wide range of APIs, including antibiotics, hormones, and fat-soluble vitamins. For thermally sensitive APIs, the rapid extraction process minimizes heat exposure, reducing the risk of active ingredient degradation.

API Reaction Liquid Extraction Process

The process for extracting API reaction liquids using the CWL-M centrifugal extractor includes the following steps:

1.Preparation Stage: Inspect the quality of the reaction liquid and extractant, calibrate equipment parameters, and ensure proper sealing.
2.Extraction and Separation: The reaction liquid and extractant are pumped into the centrifugal extractor at an optimized ratio. Mass transfer is completed within the mixing zone (in <10 seconds), followed by separation driven by centrifugal force; the API becomes enriched in the organic phase and is collected separately.
3.Post-Treatment Stage: To further increase purity, fresh extractant can be used for washing. The API-containing organic phase is then subjected to evaporation/concentration, crystallization, filtration, and drying to obtain purified API solids.

Operational Optimization Tips:
Adjust rotation speed and residence time according to density differences.
Control feed rate to match processing capacity.
Select extractants with high compatibility with the API and easy recovery, such as ethyl acetate or methyl tert-butyl ether (MTBE).

Industry Application Cases

In the production of a certain antibiotic API, the reaction liquid contained the target antibiotic along with multiple by-products. By using the centrifugal extractor and optimizing process parameters, the target component was efficiently extracted, impurities were effectively removed, and product purity met stringent quality standards. A leading pharmaceutical group recently completed a multi-stage centrifugal extractor procurement project, highlighting that top-tier industry players are increasingly recognizing and adopting centrifugal extraction technology.

Tiei Extraction’s Pharmaceutical Industry Solutions

The CWL-M series centrifugal extractor from Zhengzhou Tiei Extraction is specifically designed for the pharmaceutical industry, constructed from 316L stainless steel or fluoropolymer materials, providing corrosion resistance, easy cleaning, and no risk of leachables. The equipment features a modular design with flexible stage configuration to meet diverse separation requirements. Integrated CIP/SIP functionality ensures compliance with sterile API production needs, while an intelligent control system enables real-time monitoring and data recording, meeting data integrity requirements.

As the pharmaceutical industry continues to demand higher quality, efficiency, and sustainability, adopting advanced continuous centrifugal extraction technology has become a consensus among leading global pharmaceutical companies. Zhengzhou Tiei Extraction is committed to providing high-performance, highly reliable centrifugal extraction solutions, helping pharmaceutical manufacturers overcome bottlenecks in API reaction liquid extraction and enhance core competitiveness.
Email: sales@tieiextraction.com
Whatsapp: +86 19069612820